Trial · NCT03354598
Adverse events24
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 24
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Diarrhea | Gastrointestinal disorders | Sulopenem-etzadroxil/Probenecid | 103 | 833 | 947 |
| other | Diarrhea | Gastrointestinal disorders | Ciprofloxacin | 21 | 827 | 91 |
| serious | Diarrhoea | Gastrointestinal disorders | Sulopenem-etzadroxil/Probenecid | 0 | 833 | 0 |
| serious | Diarrhoea | Gastrointestinal disorders | Ciprofloxacin | 1 | 827 | 1 |
| serious | Abdominal pain upper | Gastrointestinal disorders | Sulopenem-etzadroxil/Probenecid | 1 | 833 | 1 |
| serious | Abdominal pain upper | Gastrointestinal disorders | Ciprofloxacin | 0 | 827 | 0 |
| serious | small intestine obstruction | Gastrointestinal disorders | Sulopenem-etzadroxil/Probenecid | 1 | 833 | 1 |
| serious | small intestine obstruction | Gastrointestinal disorders | Ciprofloxacin | 0 | 827 | 0 |
| serious | chest pain | General disorders | Sulopenem-etzadroxil/Probenecid | 1 | 833 | 1 |
| serious | chest pain | General disorders | Ciprofloxacin | 0 | 827 | 0 |
| serious | Bile duct stone | Hepatobiliary disorders | Sulopenem-etzadroxil/Probenecid | 0 | 833 | 0 |
| serious | Bile duct stone | Hepatobiliary disorders | Ciprofloxacin | 1 | 827 | 1 |
| serious | Pneumonia | Infections and infestations | Sulopenem-etzadroxil/Probenecid | 0 | 833 | 0 |
| serious | Pneumonia | Infections and infestations | Ciprofloxacin | 1 | 827 | 1 |
| serious | pyelonephritis acute | Infections and infestations | Sulopenem-etzadroxil/Probenecid | 1 | 833 | 1 |
| serious | pyelonephritis acute | Infections and infestations | Ciprofloxacin | 0 | 827 | 0 |
| serious | urosepsis | Infections and infestations | Sulopenem-etzadroxil/Probenecid | 1 | 833 | 1 |
| serious | urosepsis | Infections and infestations | Ciprofloxacin | 0 | 827 | 0 |
| serious | lung adenocarcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Sulopenem-etzadroxil/Probenecid | 1 | 833 | 1 |
| serious | lung adenocarcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Ciprofloxacin | 0 | 827 | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03354598/events